Patent · US Active

KRas G12C inhibitors

US10633381B2 · kind B2 · utility

3Cited by
4References
7Claims
0Family size

Assignees

Inventors

Key dates

Filing dateOct 29, 2018
Grant dateApr 28, 2020
Priority date
Expiry dateOct 29, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.